Clinical Trial Update: Evaluating ABX-EGF Extended Therapy in Subjects With MetastaticColorectal Cancer [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 evaluation of ABX-EGF extended therapy in subjects with metastatic colorectal cancer. The trial status is comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• ABX-EGF (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED